Clinical Trials Directory

Trials / Completed

CompletedNCT04812951

Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in Post Surgical Ocular Surface System Failure Within The Age

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Campus Bio-Medico University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Use of Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in cataract Surgery

Detailed description

To asses ocular discomfort symptoms and signs and inflammatory biomarkers after preoperative topical cyclosporine 0.1% eye drops therapy in high risk elder population after a specific insult such as cataract surgery.

Conditions

Interventions

TypeNameDescription
DRUGCycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsionone cyclosporine 0.1% eye drop twice a day for 30 preoperative days
DEVICEcationorm eye dropsone cationorm eye drop twice a day for 30 preoperative days

Timeline

Start date
2021-02-17
Primary completion
2021-06-18
Completion
2022-02-23
First posted
2021-03-24
Last updated
2023-02-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04812951. Inclusion in this directory is not an endorsement.